Expression of TGF-β Receptor ALK-5 Has a Negative Impact on Outcome of Patients With Acute Myeloid Leukemia

Leukemia - United Kingdom
doi 10.1038/leu.2010.273
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Prognostic Impact of MYH9 Expression on Patients With Acute Myeloid Leukemia

Oncotarget
Oncology
2016English

Abnormal Expression of TGF-beta Type II Receptor Isoforms Contributes to Acute Myeloid Leukemia

Oncotarget
Oncology
2016English

High Expression of miR-25 Predicts Favorable Chemotherapy Outcome in Patients With Acute Myeloid Leukemia

Cancer Cell International
Cancer ResearchOncologyGenetics
2019English

Outcome of Patients With Therapy-Related Acute Myeloid Leukemia With or Without a History of Myelodysplasia

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2016English

Philadelphia Chromosome‐negative Acute Leukemia in Chronic Myeloid Leukemia

American Journal of Hematology
Hematology
2019English

Impact of Fludarabine-Based Induction Therapy on Outcome of FLT3−/NPM1+ Cytogenetically Normal Acute Myeloid Leukemia

American Journal of Hematology
Hematology
2017English

Simpson's Paradox and the Impact of Different DNMT3A Mutations on Outcome in Younger Adults With Acute Myeloid Leukemia

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2015English

Prognosis of Patients With a Second Relapse of Acute Myeloid Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2000English

SALL1 Expression in Acute Myeloid Leukemia

Oncotarget
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy